Epidemiology of FMF Worldwide

Rare Diseases of the Immune System

Volumn 3, Issue , 2015, Pages 81-90

  Cerrito, Lucia ^a   Sicignano, Ludovico Luca ^a   Verrecchia, Elena ^a   Manna, Raffaele ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

Familial Mediterranean Fever; Familial Mediterranean Fever Patient; Mediterranean Population; MEFV Gene; Middle East

Indexed keywords

EID: 85016336345     PISSN: 22826505     EISSN: 22836403     Source Type: Book Series    
DOI: 10.1007/978-3-319-14615-7_5     Document Type: Chapter

References (61)

1. Heller H, Sohar E, Kariv I, Sherf L. Familial Mediterranean fever. Harefuah. 1955;48:91.
2. Siegal S. Benign paroxysmal peritonitis. Ann Intern Med. 1945;23:1–21.
3. Mamou H, Cattan R. La maladie périodique (sur 14 cas personnels dont 8 compliqués de néphropathies). Semaine hôp. Paris. 1952;28:1062.
4. Tunca M, Akar S, Onen F, et al. Familial Mediterranean fever (FMF) in Turkey: results of a nationwide multicenter study. Medicine (Baltimore). 2005;84(1):1–11.
5. Zaks N, Shinar Y, Padeh S, et al. Analysis of the three most common MEFV mutations in 412 patients with familial Mediterranean fever. Isr Med Assoc J. 2003;5(8):585–8.
6. Tchernitchko D, Legendre M, Cazeneuve C, Delahaye A, Niel F, Amselem S. The E148Q MEFV allele is not implicated in the development of familial Mediterranean fever. Hum Mutat. 2003;22(4):339–40.
7. Chaabouni HB, Ksantini M, M’Rad R, et al. MEFV mutations in Tunisian patients suffering from familial Mediterranean fever. Semin Arthritis Rheum. 2007;36(6):397–401.
8. Ippocrate, Aforismi e Giuramento, Tascabili Economici Newton, Roma, 1994.
9. Ben-Chetrit E, Levy M. Familial Mediterranean fever. Lancet. 1998;351:659–64.
10. Eliakim M, Levy M, Ehrenfeld M. Recurrent polyserositis (familial Mediterranean fever, periodic disease). New York: Elsevier North-Holland; 1981. p. 5–14.
11. Touitou I. The spectrum of familial Mediterranean fever (FMF) mutations. Eur J Hum Genet. 2001;9:473–83.
12. Cobankara V, Fidan G, Turk T, Zencir M, Colakoglu M, Ozen S. The prevalence of familial Mediterranean fever in the Turkish province of Denizli: a field study with a zero patient design. Clin Exp Rheumatol. 2004;22 Suppl 34:S27–30.
13. Sarkisian T, Ajrapetian H, Beglarian A, Shahsuvarian G, Egiazarian A. Familial Mediterranean fever in Armenian population. Georgian Med News. 2008;156:105–11.
14. Nucera G, La Regina G, Diaco ML, Neri G, Gasbarrini G, Manna R. La febbre mediterranea familiare: un’antica eredità. Ann Ital Med Int Vol 18, N 3 Luglio-Settembre 2003.
15. Daniels M, Shohat T, Brenner-Ullman A, Shohat M. Familial Mediterranean fever: high gene frequency among the non-Ashkenazic and Ashkenazic Jewish populations in Israel. Am J Med Genet. 2005;55:311–4.
16. Medlej-Hashim M, Serre JL, Corbani S, Saab O, Jalkh N, Delague V, et al. Familial Mediterranean fever (FMF) in Lebanon and Jordan: a population genetics study and report of three novel mutations. Eur J Med Genet. 2005;48:412–20.
17. Mattit H, Joma M, Al-Cheikh S, El-Khateeb M, Medlej-Hashim M, Salem N, et al. Familial Mediterranean fever in the Syrian population: gene mutation frequencies, carrier rates and phenotype-genotype correlation. Eur J Med Genet. 2006;49:481–6.
18. Medlej-Hashim M, Chouery E, Salem N, Delague V, Lefranc G, Loiselet J, Mégarbané A. Familial Mediterranean fever in a large Lebanese family: multiple MEFV mutations and evidence for a Founder effect of the p.[M694I] mutation. Eur J Med Genet. 2011;54:50–e 54.
19. Medlej-Hashim M, Loiselet J, Lefranc G, Mégarbané A. La fièvre méditerranéenne familiale (FMF): du diagnostic au traitment. Cah Santé. 2004;14:261–6.
20. Gershoni-Baruch R, Shinawi M, Kasinetz L, Badarnah K, Riva B. Familial Mediterranean fever: prevalence, penetrance and genetic drift. Eur J Med Genet. 2001;9:634–7.
21. Cattan D. MEFV mutation carriers and diseases other than familial Mediterranean fever: proved and non-proved associations; putative biological advantage. Curr Drug Targets Inflamm Allergy. 2005;4:105–12.
22. Chae JJ, Komarow HD, Cheng J, Wood G, Raben N, Liu P, Kastner D. Targeted disruption of pyrin, the FMF protein, causes heightened sensitivity to endotoxin and a defect in macrophage apoptosis. Mol Cell. 2003;11:591–604.
23. Wang J, Wakeham J, Harknass R, Xing ZJ. Macrophages are a significant source of type 1 cytokines during mycobacterial infection. Clin Invest. 1999;103:1023–9.
24. Lipsitch M, Sousa A. Historical intensity of natural selection for resistance to tuberculosis. Genetics. 2002;161:1599–607.
25. Ozen S. What advantage did the heterozygotes for MEFV mutations have – if any. Clin Exp Rheumatol. 2002;20 Suppl 26:69.
26. The International Familial Mediterranean Fever Consortium. Ancient missense mutations in a new member of the RoRet gene family are likely to cause familial Mediterranean fever. Cell. 1997;90:797–807.
27. Bernot A, da Silva C, Petit JL, Cruaud C, Caloustian C, Castet V, et al. Non-founder mutations in the MEFV gene establish this gene as the cause of familial Mediterranean fever (FMF). Hum Mol Genet. 1998;7:1317–25.
28. Milhavet F, Cuisset L, Hoffman HM, Slim R, El-Shanti H, Aksentijevich I, et al. The Infevers autoinflammatory mutation online registry: update with new genes and functions. Hum Mutat. 2008;29:803–8.
29. Anna Aldea A, Calafell F, Aróstegui JI, Lao O, Rius J, Plaza S, Masó M, Vives J, Buades J, Yagüe J. The west side story: MEFV haplotype in Spanish FMF patients and controls, and evidence of high LD and a recombination “hot-spot” at the MEFV locuS. Hum Mutat. 2004;23(4):399.
30. Ben-Chetrit E, Touitou I. Familial Mediterranean fever in the World. Arthritis Rheum (Arthritis Care Res). 2009;61(10):1447–53.
31. Aksentijevich I, Torosyan Y, Samuels J, Centola M, Pras E, Chae JJ, et al. Mutation and haplotype studies of familial Mediterranean fever reveal new ancestral relationships and evidence for a high carrier frequency with reduced penetrance in the Ashkenazi Jewish population. Am J Hum Genet. 1999;64:949–62.
32. Tomiyama N, Higashiuesato Y, Oda T, Baba E, Harada M, Azuma M, Yamashita T, Uehara K, Miyazato A, Hatta K, Ohya Y, Iseki K, Jinno Y, Takishita S. MEFV mutation analysis of familial Mediterranean fever in Japan. Clin Exp Rheumatol. 2008;26(1):13–7.
33. La Regina M, Nucera G, Diaco M, Procopio A, Gasbarrini G, Notarnicola C, Kone-Paut I, Touitou I, Manna R. Familial Mediterranean fever is no longer a rare disease in Italy. Eur J Hum Genet. 2003;11(1):50–6.
34. Data acquired by courtesy of Professor Raffaele Manna – Periodic Fever Research Center-UCSC-Rome (2013).
35. Nucera G, La Regina M, Diaco ML, Neri G, Gasbarrini GB, Manna R. La Febbre Mediterranea Familiare: un’antica eredità.
36. La Regina M, Nucera G, Diaco M, Federico G, Manna R, Gasbarrini G. Why Europeans should study hereditary inflammatory disorders. Clin Exp Rheumatol. 2002;20 Suppl 26:S92–3.
37. Manna R, La Regina M, Nucera G, Touitou I, Gasbarrini G. Episodic febrile auto-inflammatory diseases (EFAIDs) in the Mediterranean area. Eur J Intern Med. 2001;12:147.
38. Piazza A, Cappello N, Olivetti E, Rendine S. A genetic history of Italy. Ann Hum Genet 1988; 52 (Part 3): 203–13. French Familial Mediterranean Fever Consortium. A candidate gene for familial Mediterranean fever. Nat Genet. 1997;17:25–31.
39. Konstantopoulos K, Kanta A, Deltas C, Atamian V, Mavrogianni D, Tzioufas AG, Kollainis I, Ritis K, Moutsopoulos H. Familial Mediterranean fever associated pyrin mutations in Greece. Ann Rheum Dis. 2003;62:479–81.
40. Giaglis S, Papadopoulos V, Kambas K, et al. MEFV alterations and population genetics analysis in a large cohort of Greek patients with familial Mediterranean fever. Clin Genet. 2007;71:458–67.
41. Papadopoulos VP, Giaglis S, Mitroulis I, Ritis K. The population genetics of familial Mediterranean fever: a meta-analysis study. Ann Hum Genet. 2008;72:752–61.
42. Fragouli E, Eliopoulos E, Petraki E, Sidiropoulos P, Aksentijevich I, Galanakis E, Kritikos H, Repa A, Fragiadakis G, Boumpas DT, Goulielmos GN. Familial Mediterranean fever in Crete: a genetic and structural biological approach in a population of intermediate risk. Clin Genet. 2008;73:152–9.
43. Cornelius N, Duno M. Molecular evaluation of 458 patients referred with a clinical diagnosis of familial Mediterranean fever in Scandinavia. Rheumatol Int. 2011;31:1531–3.
44. Lainka E, Bielak M, Lohse P, Timmann C, Stojanov S, von Kries R, Niehues T, Neudorf U. Familial Mediterranean fever in Germany: epidemiological, clinical, and genetic characteristics of a pediatric population. Eur J Pediatr. 2012;171:1775–85.
45. Kisacik B, Yildirim B, Tasliyurt T. Increased frequency of familial Mediterranean fever in northern Turkey: a population based study. Rheumatol Int. 2009;11:1307–9.
46. Onen F, Sumer H, Turkay S, et al. Increased frequency of familial Mediterranean fever in central Anatolia, Turkey. Clin Exp Rheumatol. 2004;22(4 Suppl 34):S31–3.
47. Ozen S, Frenkel J, Ruperto N, et al. The Eurofever project: towards better care for autoinflammatory diseases. Eur J Pediatr. 2011;170:445–52.
48. Ozen S, Aktay N, Lainka E, Duzova A, Bakkaloglu A, Kallinich T. Disease severity in children and adolescents with familial Mediterranean fever: a comparative study to explore environmental effects on a monogenic disease. Ann Rheum Dis. 2009;68:246–8.
49. Giese A, Örnek A, Kilic L, Kurucay M, Şendur SN, Lainka E, Henning BF. Disease severity in adult patients of Turkish ancestry with familial Mediterranean fever living in Germany or Turkey. Does the country of residence affect the course of the disease? J Clin Rheumatol. 2013;19(5):246–51.
50. Ben-Zvi I, Brandt B, Berkun Y, Lidar M, Livneh A. The relative contribution of environmental and genetic factors to phenotypic variation in familial Mediterranean fever (FMF) Gene. 2012;491(2):260–3.
51. Mimouni A, Magal N, Stoffman N, Shohat T, Minasian A, Krasnov M, Halpern GJ, Rotter JI, Fischel-Ghodsian N, Danon YL, Shohat M. Familial Mediterranean fever: effects of genotype and ethnicity on inflammatory attacks and amyloidosis. Pediatrics. 2000;105(5):E70.
52. Touitou I, Sarkisian T, Medlej-Hashim M, et al. Country as the primary risk factor for renal amyloidosis in familial Mediterranean fever. Arthritis Rheum. 2007;56:1706–12.
53. Schwabe AD, Peters RS. Familial Mediterranean fever in Armenians. Analysis of 100 cases. Med (Baltimore). 1974;53:453–62.
54. Samuels J, Aksentijevich I, Torosyan Y, Centola M, Deng Z, Sood R, Kastner DL. Familial Mediterranean fever at the millennium. Clinical spectrum, ancient mutations, and a survey of 100 American referrals to the National Institutes o Health. Med (Baltimore). 1998;77(4):268–97.
55. Ong FS, Vakil H, Xue Y, Kuo JZ, Shah KH, Lee RB, Bernstein KE, Rimoin DL, Getzug T, Das K, Deignan JL, Rotter JI, Grody WW. The M694V mutation in Armenian-Americans: a 10-year retrospective study of MEFV mutation testing for familial Mediterranean fever at UCLA. Clin Genet. 2013;84(1):55–9.
56. Booth DR, Gillmore JD, Booth MB, et al. Pyrin/Marenostrin mutations in familial Mediterranean fever. Q J Med. 1998;91:603–6.
57. Rozenbaum M, Touitou I, Pertnoy E, Morkos S, Rosner I. A molecular basis for the absence of familial Mediterranean fever in Ethiopian Jews. Clin Exp Rheumatol. 2006;24 (5 Suppl 42):S127.
58. Migita K, Uehara R, Nakamura Y, Yasunami M, et al. Familial Mediterranean fever in Japan. Medicine (Baltimore). 2012;91(6):337–43.
59. Migita K, Agematsu K, Yazaki M, Nonaka F, Nakamura A, Toma T, Kishida D, Uehara R, Nakamura Y, Jiuchi Y, Masumoto J, Furukawa H, Ida H, Terai C, Nakashima Y, Kawakami A, Nakamura T, Eguchi K, Yasunami M, Yachie A. Familial Mediterranean fever: genotype-phenotype correlations in Japanese patients. Medicine (Baltimore). 2014;93(3):158–64.
60. Casey P, Lane M, Ameratunga R. Familial Mediterranean fever: 36 years to diagnosis. N Z Med J. 2004;117(1194):U894.
61. Kastner DL, Aksentijevich I. Intermittent and periodic arthritis syndromes, in Arthritis and Allied Conditions, 15th ed., WJ Koopman and LW Moreland, eds., (2005) pp. 1411–1461.